Abiopharma

News list

Verjus Nathalie Claude Odile 🔴 sold 5.0K shares of SEALSQ Corp (LAES) at $3.03 Transaction Date: Mar 18, 2026 | Filing ID: 000004

Full text

News bot March 19, 2026, 8:15 p.m.
🔍 Verjus Nathalie Claude Odile (Executive)

Company: SEALSQ Corp (LAES)

Report Date: 2026-03-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 5,000
Detailed Transactions and Holdings:
- Sold 5,000 shares of Ordinary Shares at $3.0258 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 185,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 24, 2025.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.09, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.